跳至主要内容
临床试验/NCT07279792
NCT07279792已完成2 期

Implications of Post-Operative Irrigation Fluid's Osmolarity on the Recurrence of Non-Muscle Invasive Bladder Cancer Following Transurethral Resection

Ain Shams University1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2024年10月1日最近更新:
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
150
试验地点
1
主要终点
Risk of Recurrence

研究概览

简要总结

This randomized controlled trial will evaluate the efficacy of three bladder irrigation solutions - distilled water (DW), normal saline (NS), and hypertonic saline (HS) - as continuous bladder irrigation (CBI) following transurethral resection of non-muscle invasive bladder cancer (NMIBC). Short term (6 months) recurrence and progression free survival are mainly evaluated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients of non-muscle invasive urinary bladder urothelial carcinoma amenable for complete resection

排除标准

  • Patients with post-operative complications that need prolonged irrigation.
  • Patient who underwent incomplete resection during TURBT.
  • When large bladder perforation was suspected during TURBT.
  • Patients with chronic kidney disease.
  • Muscle invasive disease

研究组 & 干预措施

Continuous Bladder Irrigation with distilled water

Active Comparator

干预措施: Continuous Bladder Irrigation with distilled water (Drug)

Continuous Bladder Irrigation with normal saline

Active Comparator

干预措施: Continuous Bladder Irrigation with normal saline (Drug)

Continuous Bladder Irrigation with hypertonic saline

Active Comparator

干预措施: Continuous Bladder Irrigation with hypertonic saline (Drug)

结局指标

主要结局

Risk of Recurrence

时间窗: 6 months

Risk of progression of bladder cancer

时间窗: 6 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验